NCT00355342 - Bone Mineral Density Study In Patients With Chronic Obstructive Pulmonary Disease. DISKUS® Inhaler is a Trademark of the GSK Group of Companies. | Biotech Hunter

Enrollment

186

Participants

Timeline

Start Date

April 28, 2004

Primary Completion Date

September 6, 2007

Study Completion Date

September 6, 2007

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

Salmeterol 50 mcg BID

Salmeterol xinafoate 50 mcg strength DISKUS inhaler (formulated with lactose), BID in the morning and evening.

DRUG

Fluticasone Propionate/Salmeterol 250/50 mcg BID

Fluticasone propionate/salmeterol xinafoate combination product 250/50mcg strength DISKUS inhaler (formulated with lactose), BID in the morning and evening.

DEVICE

DISKUS inhaler

Each participant received study medication via the DISKUS, for one of two possible treatment groups. Each DISKUS contained 60 doses of study medication. Participants were instructed to administer medication BID (one inhalation in the morning and one inhalation in the evening) approximately 12 hours apart for 156-week treatment period.

Trial Locations (37)

10708

GSK Investigational Site, Bronxville

23225

GSK Investigational Site, Richmond

23249

GSK Investigational Site, Richmond

28207

GSK Investigational Site, Charlotte

29303

GSK Investigational Site, Spartanburg

29651

GSK Investigational Site, Greer

29681

GSK Investigational Site, Simpsonville

30342

GSK Investigational Site, Atlanta

32205

GSK Investigational Site, Jacksonville

33316

GSK Investigational Site, Fort Lauderdale

33321

GSK Investigational Site, Tamarac

34239

GSK Investigational Site, Sarasota

37660

GSK Investigational Site, Kingsport

38372

GSK Investigational Site, Milan

49601

GSK Investigational Site, Cadillac

60064

GSK Investigational Site, North Chicago

60612

GSK Investigational Site, Chicago

63301

GSK Investigational Site, Saint Charles

67207

GSK Investigational Site, Wichita

68124

GSK Investigational Site, Omaha

75110

GSK Investigational Site, Corsicana

78205

GSK Investigational Site, San Antonio

78217

GSK Investigational Site, San Antonio

80033

GSK Investigational Site, Wheat Ridge

80528

GSK Investigational Site, Fort Collins

92103

GSK Investigational Site, San Diego

92270

GSK Investigational Site, Rancho Mirage

92835

GSK Investigational Site, Fullerton

94598

GSK Investigational Site, Walnut Creek

94705

GSK Investigational Site, Berkeley

97213

GSK Investigational Site, Portland

98226

GSK Investigational Site, Bellingham

99202

GSK Investigational Site, Spokane

99204

GSK Investigational Site, Spokane

06105

GSK Investigational Site, Hartford

02135

GSK Investigational Site, Boston

29406-7108

GSK Investigational Site, Charleston